Its mechanism of action in breast cancer was through the cascade regulations of the two E3 ubiquitin ligases (NEDD4 and SMURF1), which eventually enhanced the ubiquitination modification of HER2 at K716. Here, ERBB2 is linked to breast carcinoma.